MLSS milestonescientific.com: Company Value to Revenue

Official company branding of Milestone Scientific Inc. (MLSS)

Despite the defensive status of the business, which remains isolated from macroeconomic crises, the EV/Sales multiple valuation for Milestone Scientific (MLSS) demonstrates volatility. However, patents for pressure control and the painless The Wand tool restore confidence. Innovative computer-based injection monitoring minimizes patient stress by ensuring surgical precision. Meanwhile, 2379.31 serves as the final marker for the current enterprise value-to-revenue ratio.

milestonescientific.com (MLSS): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/19/2026

MLSS (Milestone Scientific Corporation): analytical breakdowns and indicator data

- current quotes and average value forecast:
Initial company analysis:Milestone Scientific
Manufactured products of Milestone Scientific Corp

The EV/Sales multiple determines the ratio of the total enterprise value to operating revenues, excluding the impact of debt load to provide an objective valuation of the asset. By analyzing historical EV/Sales trends, an investor can identify if an asset is overbought on news, which is particularly critical for Milestone Scientific (MLSS), whose resilience to macro risks and stable demand in the medical sector provide a predictable revenue foundation.

Competitor analysis for Milestone Scientific

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|EV/Sales Multiple KRMD|Total Company Value-to-Revenue Ratio Nyxoah, S.A.|Microbot Medical Inc - Company Value to Revenue|Total Company Value-to-Revenue Ratio Pro-Dex Inc. (PDEX)|Zentek - EV/Sales Multiple|Elutia (ELUT) - Company Value to Revenue|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple